Cargando…

Pathways to the diagnosis of lung cancer in the UK: a cohort study

BACKGROUND: Lung cancer is the commonest cause of cancer death in the UK. Patients generally present to their general practitioner, but the pathway of diagnosis from first symptom to diagnosis has not been mapped. We performed a cohort study of 246 patients with lung cancer in Exeter, Devon UK. All...

Descripción completa

Detalles Bibliográficos
Autores principales: Barrett, Jacqueline, Hamilton, William
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2397410/
https://www.ncbi.nlm.nih.gov/pubmed/18485242
http://dx.doi.org/10.1186/1471-2296-9-31
_version_ 1782155619685367808
author Barrett, Jacqueline
Hamilton, William
author_facet Barrett, Jacqueline
Hamilton, William
author_sort Barrett, Jacqueline
collection PubMed
description BACKGROUND: Lung cancer is the commonest cause of cancer death in the UK. Patients generally present to their general practitioner, but the pathway of diagnosis from first symptom to diagnosis has not been mapped. We performed a cohort study of 246 patients with lung cancer in Exeter, Devon UK. All patients had their cancer symptoms, referrals and diagnoses identified and dated using their doctors' records. RESULTS: Three main routes to diagnosis emerged. The first was the expected route of outpatient referral; 150 (61% of the cohort) of patients took this route, although only 110 (45% of the whole cohort, 73% of those referred to outpatients) were referred to a respiratory department. 56 (23%) were admitted as an emergency, having previously described a lung cancer symptom to their doctor. 26 patients (11%) had no symptom of lung cancer reported before their diagnosis. The interval from first symptom to referral was similar across the different pathways. However, the referral to diagnosis interval was longer in patients misdirected to other outpatient departments (66 days, interquartile range 37,110) than those sent to respiratory clinics (29 days, 17,61) or admitted as an emergency (16 days 8,40); p < 0.001. CONCLUSION: Only a minority of lung cancer patients follow the traditional route to diagnosis. Clinical and research efforts need to consider the alternative routes if they are to maximise their impact on speed of diagnosis.
format Text
id pubmed-2397410
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-23974102008-05-29 Pathways to the diagnosis of lung cancer in the UK: a cohort study Barrett, Jacqueline Hamilton, William BMC Fam Pract Research Article BACKGROUND: Lung cancer is the commonest cause of cancer death in the UK. Patients generally present to their general practitioner, but the pathway of diagnosis from first symptom to diagnosis has not been mapped. We performed a cohort study of 246 patients with lung cancer in Exeter, Devon UK. All patients had their cancer symptoms, referrals and diagnoses identified and dated using their doctors' records. RESULTS: Three main routes to diagnosis emerged. The first was the expected route of outpatient referral; 150 (61% of the cohort) of patients took this route, although only 110 (45% of the whole cohort, 73% of those referred to outpatients) were referred to a respiratory department. 56 (23%) were admitted as an emergency, having previously described a lung cancer symptom to their doctor. 26 patients (11%) had no symptom of lung cancer reported before their diagnosis. The interval from first symptom to referral was similar across the different pathways. However, the referral to diagnosis interval was longer in patients misdirected to other outpatient departments (66 days, interquartile range 37,110) than those sent to respiratory clinics (29 days, 17,61) or admitted as an emergency (16 days 8,40); p < 0.001. CONCLUSION: Only a minority of lung cancer patients follow the traditional route to diagnosis. Clinical and research efforts need to consider the alternative routes if they are to maximise their impact on speed of diagnosis. BioMed Central 2008-05-18 /pmc/articles/PMC2397410/ /pubmed/18485242 http://dx.doi.org/10.1186/1471-2296-9-31 Text en Copyright © 2008 Barrett and Hamilton; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Barrett, Jacqueline
Hamilton, William
Pathways to the diagnosis of lung cancer in the UK: a cohort study
title Pathways to the diagnosis of lung cancer in the UK: a cohort study
title_full Pathways to the diagnosis of lung cancer in the UK: a cohort study
title_fullStr Pathways to the diagnosis of lung cancer in the UK: a cohort study
title_full_unstemmed Pathways to the diagnosis of lung cancer in the UK: a cohort study
title_short Pathways to the diagnosis of lung cancer in the UK: a cohort study
title_sort pathways to the diagnosis of lung cancer in the uk: a cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2397410/
https://www.ncbi.nlm.nih.gov/pubmed/18485242
http://dx.doi.org/10.1186/1471-2296-9-31
work_keys_str_mv AT barrettjacqueline pathwaystothediagnosisoflungcancerintheukacohortstudy
AT hamiltonwilliam pathwaystothediagnosisoflungcancerintheukacohortstudy